Quick overview
Sermorelin is a growth hormone–releasing hormone (GHRH 1–29) analogue. In practice, “dosage” depends on goals, clinical history, product strength, and whether other growth hormone secretagogues are used. Formal dosing should be set by a qualified prescriber with monitoring.
- Primary medically used form: subcutaneous injection of a reconstituted, lyophilised vial.
- Supervised care may consider age, IGF‑1 baseline, sleep quality, metabolic profile and co‑medications.
- Internet protocols often cite fixed microgram doses and bedtime timing to align with natural GH pulses. Evidence quality varies.
Product forms and strengths
Most references to sermorelin dosage relate to injectable products dispensed as lyophilised powder in multi‑dose vials. After reconstitution with bacteriostatic water, doses are drawn for subcutaneous injection.
- Common compounded vial strengths: 2 mg, 5 mg and 15 mg. Exact strength varies by pharmacy and prescription.
- Route: subcutaneous injection. Intranasal and troche forms are advertised by some sellers; reliable human bioavailability data for these routes is limited, and absorption may be inconsistent.
- Measuring: doses are often discussed in micrograms (mcg). Syringe markings reflect volume, not mass; follow your prescriber’s instructions for concentration and draw‑up.
- Storage: many products require refrigeration after reconstitution and have limited beyond‑use dates. Check your label.
For technique and hygiene basics, see the Peptide Injection Guide.
How clinicians may set sermorelin doses
In supervised care, dosing is individualised. Clinicians may consider:
- Baseline biomarkers (for example, IGF‑1 within age‑adjusted range), sleep and recovery history
- Body mass, age and comorbidities (e.g., diabetes risk, thyroid status)
- Medication interactions (notably glucocorticoids, which can blunt GH responses)
- Goals and timeframe (sleep/recovery support vs longer body composition goals)
Monitoring can include symptom changes, sleep quality, and periodic labs as clinically indicated. Dose, timing and cycle length are then adjusted to response and tolerability.
Common protocol claims you’ll see online
Fixed, non‑individualised protocols are widely shared on forums and by vendors. These are not medical advice, but you may see claims such as:
- Fixed nightly doses described in micrograms (for example, 100–500 mcg once daily before bed)
- Split dosing (morning and pre‑bed) or pre‑/post‑training dosing
- Timing on an empty stomach or away from carbohydrate/fat to “avoid blunting GH”
- 8–12+ week “cycles,” sometimes with deload weeks
Evidence for exact numbers and rigid timing rules is mixed, and responses vary. If you are considering any protocol, seek a qualified prescriber’s guidance and monitoring first.
Timing, food and sleep
- Bedtime dosing is frequently used to coincide with the first nocturnal GH pulse and to reduce nuisance effects like transient flushing.
- Some people are advised to avoid large meals close to dosing; carbohydrate‑heavy meals may blunt GH responses in some contexts. The practical impact varies by individual.
- Good sleep hygiene remains essential. Sermorelin does not replace sleep quality practices.
Cycle length and adjustments
Online guidance often discusses 8–12+ week courses with reassessment. In clinical settings, duration depends on goals, response and safety. Dose or frequency may be reduced, paused, or discontinued based on outcomes or side effects.
If response is minimal at a given dose, prescribers may adjust within a supervised range or evaluate sleep, nutrition and medication factors first.
Combinations people ask about
You may see sermorelin discussed alongside other growth hormone secretagogues:
- CJC‑1295 and ipamorelin are frequently compared or combined in online discussions.
- Combination approaches can alter total GH‑axis signalling and side‑effect profiles. Overshooting can increase risks like edema, joint aches, or glucose changes.
Before stacking agents, review comparisons: CJC‑1295 vs Sermorelin, Ipamorelin vs Sermorelin, Tesamorelin vs Sermorelin.
Safety notes that influence dosage
- Side effects can include headache, flushing, dizziness, nausea, transient injection‑site reactions, water retention, joint aches and, rarely, changes in glucose handling. See the Sermorelin Side Effects page for detail.
- Medical history matters: prior malignancy, uncontrolled sleep apnoea, uncontrolled diabetes, active proliferative retinopathy and pregnancy/breastfeeding are common exclusion or caution areas. Discuss your history with a prescriber.
- Drug interactions: glucocorticoids can blunt GH responses; thyroid status can modify outcomes; other GH‑axis agents may compound effects.
- Monitoring: many clinicians assess symptoms and may track labs such as IGF‑1 periodically, adjusting dosage accordingly.
Also review the cross‑compound Peptide Side Effects Guide.
Dose and handling mistakes to avoid
- Guessing concentrations after reconstitution. Always calculate mcg per mL based on your vial strength and added diluent, and follow your script.
- Using non‑sterile technique. See the Peptide Injection Guide.
- Improper storage leading to potency loss. Follow label storage temperature and beyond‑use dates.
- Chasing internet “max” numbers without monitoring. Individual response and risks differ.
Australian access and why supervision matters
Access pathways and product status in Australia affect what “dosage” practically means. Compounded strengths, rules and oversight can differ between providers. Learn the basics here:
Related reading to round out dosage decisions
Frequently asked questions
What is a typical sermorelin dosage?
Online sources commonly cite fixed microgram doses once nightly (for example, 100–500 mcg). In supervised care, dosing is individualised based on history, goals and monitoring. Always follow your prescriber’s instructions.
Does body weight determine the dose?
Some clinicians consider body size among several factors, but fixed microgram ranges are also used in practice. The appropriate approach depends on your clinical picture and monitoring plan.
When should I take sermorelin?
Bedtime dosing is frequently chosen to align with natural GH pulses. Timing around meals is sometimes adjusted to minimise potential blunting effects of carbohydrate‑heavy meals. Follow your provider’s plan.
How long is a sermorelin cycle?
People often discuss 8–12+ week courses, but duration should reflect your goals, response and any side effects under medical supervision.
Can I combine sermorelin with CJC‑1295 or ipamorelin?
Combinations are discussed online but can increase total GH‑axis signalling and side effects. Review our comparisons and seek medical guidance before combining agents.
Are troches or nasal sprays effective?
Reliable human bioavailability data for non‑injectable sermorelin is limited. Injectable products are the most referenced in clinical contexts.
Is sermorelin legal in Australia?
Access is regulated. Review Is Sermorelin Legal in Australia? and speak with a licensed provider.
What side effects should I watch for?
Headache, flushing, nausea, water retention and joint aches are reported. See Sermorelin Side Effects and seek medical advice promptly if concerned.
Where can I learn safe technique?
See the Peptide Injection Guide for reconstitution, technique and hygiene basics.
Ask a question about sermorelin dosage
Send your question and we’ll connect you with information and legitimate medical pathways in Australia.
Key takeaways
- “Sermorelin dosage” depends on individual factors, product strength and goals—avoid one‑size‑fits‑all numbers.
- Injectable forms have the clearest practical use; non‑injectable routes have uncertain absorption.
- Timing, cycling and combinations should be planned and monitored to balance benefit with safety.
- In Australia, understand legal access and work with qualified prescribers.